Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CAM
CAMERON INTERNATIONAL CORPORATION
CAM
|
+$294M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$293M |
| 3 |
WLL
Whiting Petroleum Corporation
WLL
|
+$213M |
| 4 |
Xcel Energy
XEL
|
+$178M |
| 5 |
McDonald's
MCD
|
+$173M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BHI
Baker Hughes
BHI
|
+$255M |
| 2 |
Exelon
EXC
|
+$209M |
| 3 |
AbbVie
ABBV
|
+$199M |
| 4 |
CenterPoint Energy
CNP
|
+$130M |
| 5 |
American Electric Power
AEP
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.56% |
| 2 | Energy | 13.05% |
| 3 | Financials | 9.97% |
| 4 | Industrials | 8.17% |
| 5 | Consumer Discretionary | 7.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3176
PUT
Prologis
PLD
$136B
| $383K | ﹤0.01% |
+8,900
| New | +$365K |
|
|
SONN
3177
DELISTED
Sonnet BioTherapeutics
SONN
| – | – |
0
| – | – |
|
|
ELLI
3178
DELISTED
Ellie Mae Inc
ELLI
| $383K | ﹤0.01% |
+9,503
| New | +$368K |
|
|
BCR
3179
CALL
DELISTED
CR Bard Inc.
BCR
| $383K | ﹤0.01% |
2,300
+500
| +28% | +$80.8K |
|
3180
Chegg
CHGG
$87.9M
| $382K | ﹤0.01% |
55,289
-30,020
| -35% | -$194K |
|
3181
Orion
OEC
$337M
| $382K | ﹤0.01% |
22,460
-52,767
| -70% | -$846K |
|
|
ZSPH
3182
DELISTED
ZS PHARMA INC COMS TK (DE)
ZSPH
| $382K | ﹤0.01% |
+9,180
| New | +$362K |
|
3183
1-800-Flowers.com
FLWS
$251M
| $379K | ﹤0.01% |
45,939
+26,777
| +140% | +$217K |
|
3184
PUT
Bank OZK
OZK
$5.36B
| $379K | ﹤0.01% |
+10,000
| New | +$349K |
|
|
TMUSP
3185
DELISTED
T-Mobile US, Inc.5.50% Mandatory Convertible Preferred Stock, Series A
TMUSP
| $379K | ﹤0.01% |
+7,147
| New | +$371K |
|
3186
Ameris Bancorp
ABCB
$5.74B
| $378K | ﹤0.01% |
+14,745
| New | +$365K |
|
3187
PUT
Acuity Brands
AYI
$10.2B
| $378K | ﹤0.01% |
+2,700
| New | +$367K |
|
3188
CALL
Pitney Bowes
PBI
$2.34B
| $378K | ﹤0.01% |
+15,500
| New | +$379K |
|
3189
PUT
Patterson-UTI
PTEN
$4.39B
| $378K | ﹤0.01% |
+22,800
| New | +$481K |
|
3190
CALL
EOG Resources
EOG
$77B
| $377K | ﹤0.01% |
4,100
-100
| -2% | -$9.31K |
|
|
AENZ
3191
DELISTED
Aenza S.A.A.
AENZ
| $377K | ﹤0.01% |
9,930
+1,367
| +16% | +$53.2K |
|
|
KIN
3192
DELISTED
Kindred Biosciences, Inc.
KIN
| $377K | ﹤0.01% |
50,640
+25,465
| +101% | +$216K |
|
|
JNPR
3193
DELISTED
Juniper Networks
JNPR
| $376K | ﹤0.01% |
16,830
-1,523,015
| -99% | -$32.4M |
|
3194
Scully Royalty
SRL
$87.6M
| $375K | ﹤0.01% |
10,607
-8,595
| -45% | -$264K |
|
3195
Tetra Tech
TTEK
$9.42B
| $375K | ﹤0.01% |
+70,210
| New | +$367K |
|
3196
Watsco Inc
WSO
$12.5B
| $375K | ﹤0.01% |
3,500
-98,662
| -97% | -$9.8M |
|
|
AL
3197
PUT
DELISTED
Air Lease Corp
AL
| $374K | ﹤0.01% |
+10,900
| New | +$383K |
|
3198
PUT
Herc Holdings
HRI
$5.22B
| $374K | ﹤0.01% |
5,000
| – | – |
|
3199
CALL
Kroger
KR
$35.8B
| $372K | ﹤0.01% |
11,600
-52,400
| -82% | -$1.52M |
|
|
SGYP
3200
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
| $372K | ﹤0.01% |
121,833
+35,083
| +40% | +$104K |
|
Similar funds
Israel Englander's Q4 2014 Portfolio in Review
As of Q4 2014, Israel Englander held 4,655 positions worth $47.2B, up 19% from $39.5B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.
Israel Englander deployed $7.43B of net new capital in Q4 2014, opening 1,009 new positions and adding to 1,528 existing holdings. Its largest new stake was Coca-Cola: 2,223,712 shares worth $93.9M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 13% a quarter earlier, followed by Energy and Financials.
On the sell side, the largest reduction was Baker Hughes, an estimated $255M trimmed.
- Israel Englander's largest Q4 2014 buy was Coca-Cola: 2,223,712 shares worth $93.9M.
- Israel Englander added most to CAMERON INTERNATIONAL CORPORATION in Q4 2014, an estimated $294M increase.
- Israel Englander's biggest Q4 2014 reduction was Baker Hughes, cutting an estimated $255M.
- Israel Englander fully exited COVIDIEN PLC COM SHS NEW (IRELAND) in Q4 2014, selling an estimated $69M.
- Israel Englander's ten largest holdings make up 9.1% of its $47.2B portfolio in Q4 2014.
- Israel Englander opened 1,009 new positions and closed 792 in Q4 2014.
- Israel Englander's portfolio value rose 19% quarter-over-quarter to $47.2B.
Based on Millennium Management's 13F filing for Q4 2014, filed 17 Feb 2015.